Immunomodulation
Also known as: immunomodulatory · immune modulation · immunoregulation
Adjusting the immune system up or down toward balance — the research theme behind thymic and defence peptides.
Immunomodulation means shifting immune activity toward a more balanced state — enhancing a weak response or calming an overactive one, rather than simply suppressing or stimulating it.
It is the central research theme for thymic peptides such as Thymosin Alpha-1 and Thymalin, and for defence peptides such as LL-37, all studied in the immune-support category.
ON THIS SITE
RELATED TERMS
Thymosin Alpha-1
Thymosin Alpha-1 (Tα1) — a thymus-derived peptide studied for immune modulation and T-cell function.
Thymalin
A thymus-gland peptide bioregulator studied for immune regulation and restoration of balanced immune function.
LL-37
A human cathelicidin antimicrobial peptide studied for host defence, wound healing and modulation of inflammation.
Inflammation / Anti-inflammatory
The body’s protective response to injury; calming excess inflammation is a target of gut- and repair-peptide research.
VIP
Vasoactive Intestinal Peptide — a 28-residue signalling peptide studied for anti-inflammatory, immune and neuroprotective effects.
Educational content, not medical advice. All products supplied for research purposes only — not for human consumption.